Akero Therapeutics, Inc. SEC Filings

Filed On	Filing
17 Feb 2026	SCHEDULE 13G/A
17 Feb 2026	SCHEDULE 13G/A
13 Feb 2026	SCHEDULE 13G/A
10 Feb 2026	SCHEDULE 13G/A
19 Dec 2025	15-12G
09 Dec 2025	25-NSE
09 Dec 2025	Form 4: Heyman Tomas J., Director Returned 9,398 shares to the issuer · Disposed of 69,000 Stock Option (Right to Buy) (Disposition to Issuer)
09 Dec 2025	Form 4: Xu Yuan, Director Returned 9,398 shares to the issuer · Disposed of 95,000 Stock Option (Right to Buy) (Disposition to Issuer)
09 Dec 2025	Form 4: Cheng Andrew, Director Returned 436,837 shares to the issuer · Disposed of 1,678,754 Stock Option (Right to Buy) (Disposition to Issuer)
09 Dec 2025	Form 4: Harrison Seth Loring, Director Returned 293,762 shares to the issuer · Disposed of 108,000 Stock Option (Right to Buy) (Disposition to Issuer)
09 Dec 2025	Form 4: Graham G. Walmsley, Director Returned 1,302,398 shares to the issuer · Disposed of 15,000 Stock Option (Right to Buy) (Disposition to Issuer)
09 Dec 2025	Form 4: Judy Chou, Director Returned 9,398 shares to the issuer · Disposed of 82,000 Stock Option (Right to Buy) (Disposition to Issuer)
09 Dec 2025	Form 4: Rolph Timothy, Chief Scientific Officer Returned 282,149 shares to the issuer · Disposed of 406,014 Stock Option (Right to Buy) (Disposition to Issuer)
09 Dec 2025	Form 4: Iwicki Mark T, Director Returned 9,398 shares to the issuer · Disposed of 240,307 Stock Option (Right to Buy) (Disposition to Issuer)
09 Dec 2025	Form 4: Gangloff Scott A., Chief Technology Officer Returned 26,351 shares to the issuer · Disposed of 296,100 Stock Option (Right to Buy) (Disposition to Issuer)
09 Dec 2025	Form 4: White William Richard, Chief Financial Officer Returned 57,752 shares to the issuer · Disposed of 661,075 Stock Option (Right to Buy) (Disposition to Issuer)
09 Dec 2025	Form 4: Yale Catriona, Chief Development Officer Returned 74,800 shares to the issuer · Disposed of 456,575 Stock Option (Right to Buy) (Disposition to Issuer)
09 Dec 2025	Form 4: Lamy Patrick, See Remarks Returned 29,891 shares to the issuer · Disposed of 212,664 Stock Option (Right to Buy) (Disposition to Issuer)
09 Dec 2025	Form 4: Henderson Jane, Director Returned 9,398 shares to the issuer · Disposed of 93,797 Stock Option (Right to Buy) (Disposition to Issuer)
09 Dec 2025	Form 4: Young Jonathan, Chief Operating Officer Returned 260,189 shares to the issuer · Disposed of 512,082 Stock Option (Right to Buy) (Disposition to Issuer)

Comments